Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis

Mycotic demyelinating optic neuritis is a neurological disorder of the visual system caused by mycotoxins released by indoor toxic molds. Although the health effect of indoor toxic mold on the population worldwide is now one of the �emerging diseases�, its involvement in chronic demyelinating optic...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew W. Campbell, Ebere C. Anyanwu, Aristo Vojdani
Format: Article
Language:English
Published: Wiley 2003-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2003.49
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564359207845888
author Andrew W. Campbell
Ebere C. Anyanwu
Aristo Vojdani
author_facet Andrew W. Campbell
Ebere C. Anyanwu
Aristo Vojdani
author_sort Andrew W. Campbell
collection DOAJ
description Mycotic demyelinating optic neuritis is a neurological disorder of the visual system caused by mycotoxins released by indoor toxic molds. Although the health effect of indoor toxic mold on the population worldwide is now one of the �emerging diseases�, its involvement in chronic demyelinating optic neuritis has not been reported. Most of the neurological and immunologic abnormalities associated with toxic mold mycotoxins are very difficult to treat successfully, especially neural demyelination of the central and peripheral nervous systems. This paper presents the case of a 42-year-old white female, in whom chronic demyelinating optic neuritis with persistent visual defects due to chronic exposure to toxic molds was diagnosed at the age of 34 years. In spite of all the therapeutic services given to her for over 8 years, her illness persisted and was difficult to treat. However, we successfully treated her with a combination of intravenous immune globulin (IVIG) and itraconozole (Sporanox) when all other treatment modalities failed. This is probably the first report where persistent toxic mold-induced neurological and immunologic disorders were successfully treated with a combination of itraconozole and IVIG.
format Article
id doaj-art-cbfb729f782d42ef9a50d424c582e37e
institution Kabale University
issn 1537-744X
language English
publishDate 2003-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-cbfb729f782d42ef9a50d424c582e37e2025-02-03T01:11:19ZengWileyThe Scientific World Journal1537-744X2003-01-01364064610.1100/tsw.2003.49Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic NeuritisAndrew W. Campbell0Ebere C. Anyanwu1Aristo Vojdani2Medical Center for Immune, Environmental and Toxic Disorders, 25010 Oakhurst, Suite 200, Spring, Texas 77386, USAMedical Center for Immune, Environmental and Toxic Disorders, 25010 Oakhurst, Suite 200, Spring, Texas 77386, USAMedical Center for Immune, Environmental and Toxic Disorders, 25010 Oakhurst, Suite 200, Spring, Texas 77386, USAMycotic demyelinating optic neuritis is a neurological disorder of the visual system caused by mycotoxins released by indoor toxic molds. Although the health effect of indoor toxic mold on the population worldwide is now one of the �emerging diseases�, its involvement in chronic demyelinating optic neuritis has not been reported. Most of the neurological and immunologic abnormalities associated with toxic mold mycotoxins are very difficult to treat successfully, especially neural demyelination of the central and peripheral nervous systems. This paper presents the case of a 42-year-old white female, in whom chronic demyelinating optic neuritis with persistent visual defects due to chronic exposure to toxic molds was diagnosed at the age of 34 years. In spite of all the therapeutic services given to her for over 8 years, her illness persisted and was difficult to treat. However, we successfully treated her with a combination of intravenous immune globulin (IVIG) and itraconozole (Sporanox) when all other treatment modalities failed. This is probably the first report where persistent toxic mold-induced neurological and immunologic disorders were successfully treated with a combination of itraconozole and IVIG.http://dx.doi.org/10.1100/tsw.2003.49
spellingShingle Andrew W. Campbell
Ebere C. Anyanwu
Aristo Vojdani
Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis
The Scientific World Journal
title Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis
title_full Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis
title_fullStr Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis
title_full_unstemmed Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis
title_short Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis
title_sort combination of high dose intravenous immunoglobulins and itraconozole in treating chronic mycotic demyelinating optic neuritis
url http://dx.doi.org/10.1100/tsw.2003.49
work_keys_str_mv AT andrewwcampbell combinationofhighdoseintravenousimmunoglobulinsanditraconozoleintreatingchronicmycoticdemyelinatingopticneuritis
AT eberecanyanwu combinationofhighdoseintravenousimmunoglobulinsanditraconozoleintreatingchronicmycoticdemyelinatingopticneuritis
AT aristovojdani combinationofhighdoseintravenousimmunoglobulinsanditraconozoleintreatingchronicmycoticdemyelinatingopticneuritis